Apellis Pharmaceuticals (APLS) News Today $28.05 -0.17 (-0.60%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$28.12 +0.06 (+0.23%) As of 08/28/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Stocks To Watch: Apellis Pharmaceuticals Sees Relative Strength Rating Rise To 81August 27 at 2:12 PM | msn.comApellis Pharmaceuticals, Inc. $APLS Shares Acquired by Old West Investment Management LLCAugust 27 at 8:05 AM | marketbeat.comJump Financial LLC Purchases New Stake in Apellis Pharmaceuticals, Inc. $APLSAugust 27 at 7:01 AM | marketbeat.comApellis Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27 at 7:00 AM | globenewswire.comAlphaQuest LLC Increases Stock Holdings in Apellis Pharmaceuticals, Inc. $APLSAugust 26 at 5:39 AM | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Candriam S.C.A.August 25, 2025 | marketbeat.comNuveen LLC Invests $10.77 Million in Apellis Pharmaceuticals, Inc. $APLSAugust 25, 2025 | marketbeat.comInvesco Ltd. Purchases 37,741 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 25, 2025 | marketbeat.com9,577 Shares in Apellis Pharmaceuticals, Inc. $APLS Purchased by Kaufman Rossin Wealth LLCAugust 24, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Swiss National BankAugust 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 32,249 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 24, 2025 | marketbeat.comApellis Pharmaceuticals Shows Market Leadership With Jump To 82 RS RatingAugust 22, 2025 | msn.comShort Interest in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Grows By 34.0%August 22, 2025 | marketbeat.comFox Run Management L.L.C. Makes New Investment in Apellis Pharmaceuticals, Inc. $APLSAugust 22, 2025 | marketbeat.comVanguard Group Inc. Grows Stake in Apellis Pharmaceuticals, Inc. $APLSAugust 22, 2025 | marketbeat.comInsider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) General Counsel Sells 5,000 Shares of StockAugust 21, 2025 | marketbeat.comAlgert Global LLC Buys 56,328 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 16, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Stock Price Up 9.5% - What's Next?August 15, 2025 | marketbeat.comAigen Investment Management LP Buys Shares of 15,621 Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 15, 2025 | marketbeat.comApellis Pharmaceuticals: Restart Of Growth Story After Empaveli's New ApprovalAugust 14, 2025 | seekingalpha.comNational Bank of Canada FI Has $17.12 Million Stock Holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 13, 2025 | marketbeat.comFDA Approval and Strategic Deals Drive Apellis Pharmaceuticals’ Stock Higher for the WeekAugust 13, 2025 | msn.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS) and Akero Therapeutics (AKRO)August 11, 2025 | theglobeandmail.comApellis Pharmaceuticals’ Earnings Call: A Balanced OutlookAugust 8, 2025 | theglobeandmail.comING Groep NV Takes $4.03 Million Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 7, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysAugust 5, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Decreases Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 5, 2025 | marketbeat.comWhat is Wedbush's Estimate for APLS Q3 Earnings?August 4, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Announces Earnings ResultsAugust 3, 2025 | marketbeat.comEnvestnet Asset Management Inc. Increases Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)August 3, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Rating Increased to Hold at Wall Street ZenAugust 3, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 3, 2025 | marketbeat.comApellis Pharmaceuticals (APLS) Surges 17.6% on Higher Price TargetAugust 2, 2025 | msn.comRoyal Bank Of Canada Forecasts Strong Price Appreciation for Apellis Pharmaceuticals (NASDAQ:APLS) StockAugust 2, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Given New $40.00 Price Target at Cantor FitzgeraldAugust 2, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Given New $50.00 Price Target at Raymond James FinancialAugust 2, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. (APLS) Q2 2025 Earnings Call TranscriptAugust 2, 2025 | seekingalpha.comApellis Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 2, 2025 | seekingalpha.comApellis Pharmaceuticals: The Picture Becomes ClearerAugust 1, 2025 | seekingalpha.comApellis Pharmaceuticals (NASDAQ:APLS) Shares Gap Up After Earnings BeatAugust 1, 2025 | marketbeat.comWilliam Blair Issues Positive Outlook for APLS EarningsAugust 1, 2025 | marketbeat.comApellis’ EMPAVELI Approved by FDA for Rare Kidney DiseasesJuly 31, 2025 | msn.comApellis Pharmaceuticals Reports Second Quarter 2025 Financial ResultsJuly 31, 2025 | globenewswire.comWilliam Blair Issues Optimistic Forecast for APLS EarningsJuly 31, 2025 | marketbeat.comWhat To Expect From Apellis Pharmaceuticals Inc (APLS) Q2 2025 EarningsJuly 30, 2025 | finance.yahoo.comCitigroup Issues Positive Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock PriceJuly 30, 2025 | marketbeat.comApellis wins FDA label expansion for Empaveli in rare kidney disordersJuly 29, 2025 | msn.comApellis stock soars after FDA approves first C3G treatmentJuly 29, 2025 | za.investing.com Get Apellis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for APLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APLS Media Mentions By Week APLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLS News Sentiment▼1.481.03▲Average Medical News Sentiment APLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLS Articles This Week▼169▲APLS Articles Average Week Get the Latest News and Ratings for APLS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies VTRS News RDY News ASND News QGEN News MRNA News BBIO News ELAN News VRNA News ROIV News GRFS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLS) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access